H. Fiebig

发表

Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells

C. Akdis, M. Akdiş, G. Deniz, 2004, The Journal of experimental medicine.

EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification

R. G. Das, R. Van Ree, S. Vieths, 2008, Allergy.

Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment

Wayne Thomas, Karin Hoffmann-Sommergruber, Reto Crameri, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Allergen Microarray Indicates Pooideae Sensitization in Brazilian Grass Pollen Allergic Patients

R. Valenta, I. Swoboda, H. Fiebig, 2015, PloS one.

Bacterially expressed and optimized recombinant Phl p 1 is immunobiochemically equivalent to natural Phl p 1.

A. Petersen, W. Keller, H. Fiebig, 2006, Biochimica et biophysica acta.

Rapid method for arrayed investigation of IgE‐reactivity profiles using natural and recombinant allergens

H. Fiebig, O. Cromwell, A. Nandy, 2002, Allergy.

Purification and Immunobiochemical Characterization of Folding Variants of the Recombinant Major Wasp Allergen Ves v 5 (Antigen 5)

H. Fiebig, O. Cromwell, B. Weber, 2000, International Archives of Allergy and Immunology.

Standardization of Alternaria alternata: extraction and quantification of alt a 1 by using an mAb-based 2-site binding assay.

H. Fiebig, O. Cromwell, B. Weber, 1999, The Journal of allergy and clinical immunology.

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

F. Horak, R. Valenta, H. Fiebig, 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Allergen-specific immunotherapy with recombinant grass pollen allergens.

M. Jutel, H. Fiebig, O. Cromwell, 2005, The Journal of allergy and clinical immunology.

Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1

R. Valenta, V. Mahler, H. Fiebig, 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Generation of a low Immunoglobulin E‐binding mutant of the timothy grass pollen major allergen Phl p 5a

W. Keller, M. Wald, H. Fiebig, 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Reactivity of T Cells with Grass Pollen Allergen Extract and Allergoid

H. Fiebig, O. Cromwell, H. Kahler, 1999, International Archives of Allergy and Immunology.

Clinical experience with recombinant molecules for allergy vaccination.

F. Horak, H. Fiebig, O. Cromwell, 2011, Current topics in microbiology and immunology.

Strategies for recombinant allergen vaccines and fruitful results from first clinical studies.

H. Fiebig, O. Cromwell, A. Nandy, 2006, Immunology and allergy clinics of North America.

"Allergen engineering": variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity.

M. Schlaak, W. Becker, A. Bufe, 1999, Journal of immunology.

Group 13 grass allergens: structural variability between different grass species and analysis of proteolytic stability.

A. Petersen, W. Becker, H. Fiebig, 2001, The Journal of allergy and clinical immunology.

Regional sublocalization of the human CD69 gene to chromosome bands 12p12.3‐p13.2, the predicted region of the human natural killer cell gene complex

S. Schnittger, M. Strauss, C. Fonatsch, 1993, European journal of immunology.

Cytokine and Antibody Responses in Birch-Pollen-Allergic Patients Treated with Genetically Modified Derivatives of the Major Birch Pollen Allergen Bet v 1

C. Akdis, R. Valenta, H. Grönlund, 2005, International Archives of Allergy and Immunology.

Measurement of basophil‐activating capacity of grass pollen allergens, allergoids and hypoallergenic recombinant derivatives by flow cytometry using anti‐CD203c

H. Fiebig, O. Cromwell, H. Kahlert, 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Characterization of a Hypoallergenic Recombinant Bet v 1 Variant as a Candidate for Allergen-Specific Immunotherapy

W. Keller, M. Wald, H. Fiebig, 2007, International Archives of Allergy and Immunology.

Different allergenic activity of grass pollen allergens revealed by skin testing

I. Swoboda, S. Spitzauer, F. Horak, 2008, European journal of clinical investigation.

Purification strategy for recombinant Phl p 6 is applicable to the natural allergen and yields biochemically and immunologically comparable preparations.

H. Fiebig, O. Cromwell, B. Weber, 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Rapid and efficient purification of Phleum pratense major allergens Phl p 1 and group Phl p 2/3 using a two-step procedure.

H. Fiebig, O. Cromwell, S. Hagen, 1999, Journal of immunological methods.

Vaccination with genetically engineered allergens prevents progression of allergic disease

H. Grönlund, P. Valent, S. Spitzauer, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Primary structure, recombinant expression, and molecular characterization of Phl p 4, a major allergen of timothy grass (Phleum pratense).

A. Petersen, W. Becker, M. Wald, 2005, Biochemical and biophysical research communications.

Reduced IgE-Binding Capacity but Conserved Timothy Grass Pollen Allergen Phl p 5 b with ' ' Allergen Engineering ' ' : Variants of the Oliver Cromwell and

M. Schlaak, W. Becker, A. Bufe, 1999 .

T Cell Reactivity with Allergoids: Influence of the Type of APC

E. Grage‐griebenow, H. Fiebig, O. Cromwell, 2000, The Journal of Immunology.

Establishment of recombinant major allergens Bet v 1 and Phl p 5a as Ph. Eur. reference standards and validation of ELISA methods for their measurement. Results from feasibility studies.

R. Van Ree, S. Vieths, K. Buchheit, 2012, Pharmeuropa bio & scientific notes.

Molecular Characterization of Polygalacturonases as Grass Pollen-Specific Marker Allergens: Expulsion from Pollen via Submicronic Respirable Particles1

R. Valenta, P. Valent, W. Sperr, 2004, The Journal of Immunology.

Submicronic Respirable Particles Marker Allergens : Expulsion from Pollen via Polygalacturonases as Grass Pollen-Specific Molecular Characterization of

R. Valenta, P. Valent, W. Sperr, 2004 .

Mutants of the major ryegrass pollen allergen, Lol p 5, with reduced IgE‐binding capacity: candidates for grass pollen‐specific immunotherapy

R. Valenta, P. Bhalla, P. Valent, 2002, European journal of immunology.

Hypoallergenic Forms of the Ryegrass Pollen Allergen Lol p 5 as Candidates for Immunotherapy

R. Valenta, P. Bhalla, P. Valent, 2001, International Archives of Allergy and Immunology.

Hypoallergenic Mutants of the Timothy Grass Pollen Allergen Phl p 5 Generated by Proline Mutations

G. Reese, W. Keller, M. Wald, 2012, International Archives of Allergy and Immunology.

The high molecular mass allergen fraction of timothy grass pollen (Phleum pratense) between 50–60 kDa is comprised of two major allergens: Phl p 4 and Phl p 13

H. Fiebig, O. Cromwell, S. Hagen, 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Transition of recombinant allergens from bench to clinical application.

H. Fiebig, O. Cromwell, A. Nandy, 2004, Methods.

Validation of quantitative, allergen-specific ELISAs.

S. Vieths, K. Fötisch, W. Becker, 2006, Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M.

Bacterial fermentation of recombinant major wasp allergen Antigen 5 using oxygen limiting growth conditions improves yield and quality of inclusion bodies.

Walter Keller, Oliver Cromwell, W. Keller, 2006, Protein expression and purification.

Gain of structure and IgE epitopes by eukaryotic expression of the major Timothy grass pollen allergen, Phl p 1

S. Almo, R. Valenta, P. Valent, 2004, The FEBS journal.

Analytical and preparative native polyacrylamide gel electrophoresis: Investigation of the recombinant and natural major grass pollen allergen Phl p 2

A. Petersen, W. Becker, H. Fiebig, 2004, Electrophoresis.

Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain.

M. Strauss, H. Fiebig, H. Fiebig, 1993, Journal of immunology.

Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells

C. Akdis, M. Akdiş, G. Deniz, 2004, The Journal of experimental medicine.

Antibody-based methods for standardization of allergoids and recombinant hypoallergens.

H. Fiebig, O. Cromwell, A. Nandy, 2009, Arbeiten aus dem Paul-Ehrlich-Institut (Bundesinstitut fur Impfstoffe und biomedizinische Arzneimittel) Langen/Hessen.

Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives

F. Horak, R. Valenta, H. Fiebig, 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

EU Forum: The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification

R. G. Das, S. Vieths, K. Fötisch, 2008, Allergy.